Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NC PHARMA HOLDING : revenue, balance sheet and financial ratios

NC PHARMA HOLDING is a French company founded 7 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in GOUAREC (22570), this company of category PME shows in 2024 a net income positive of 152 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NC PHARMA HOLDING (SIREN 842486250)
Indicator 2024 2023 2019
Revenue N/C N/C N/C
Net income 151 945 € 119 577 € 38 501 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, NC PHARMA HOLDING generates positive net income of 152 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 39 k€ -> 152 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

151 945 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

76.494%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.321%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

51.8%

Solvency indicators evolution
NC PHARMA HOLDING

Sector positioning

Debt ratio
76.49 2024
2019
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average -10 pts over 3 years

In 2024, the debt ratio of NC PHARMA HOLDING (76.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
52.32% 2024
2019
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Average +23 pts over 3 years

In 2024, the financial autonomy of NC PHARMA HOLDING (52.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 481.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

481.221

Liquidity indicators evolution
NC PHARMA HOLDING

Sector positioning

Liquidity ratio
481.22 2024
2019
2023
2024
Q1: 132.35
Med: 897.73
Q3: 5412.13
Average

In 2024, the liquidity ratio of NC PHARMA HOLDING (481.22) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of NC PHARMA HOLDING in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 426 763€ to 2 944 480€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
426k€ 1971k€ 2944k€
1 971 903 € Range: 426 763€ - 2 944 480€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare NC PHARMA HOLDING with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about NC PHARMA HOLDING

What is the revenue of NC PHARMA HOLDING ?

The revenue of NC PHARMA HOLDING is not publicly disclosed (confidential accounts filed with INPI).

Is NC PHARMA HOLDING profitable?

Yes, NC PHARMA HOLDING generated a net profit of 152 k€ in 2024.

Where is the headquarters of NC PHARMA HOLDING ?

The headquarters of NC PHARMA HOLDING is located in GOUAREC (22570), in the department Cotes-d'Armor.

Where to find the tax return of NC PHARMA HOLDING ?

The tax return of NC PHARMA HOLDING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NC PHARMA HOLDING operate?

NC PHARMA HOLDING operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.